Filing excerpt
A response to the CRL has been submitted and we anticipate a regulatory decision and potential commercial launch in mid-2026.
Source: Autobound Signal API · 75 signals tracked for Incyte · updated
Get Incyte's live signals in Claude or ChatGPT, or by API
What changed at Incyte this week? Use Autobound signals for incyte.com.After addressing an FDA complete response letter, the company is preparing for a potential launch of a new once-daily formulation of its blockbuster drug, JAKAFI. This will require new marketing, sales enablement, and commercial support to manage the product line extension.
Filing excerpt
A response to the CRL has been submitted and we anticipate a regulatory decision and potential commercial launch in mid-2026.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10kproductLaunchGet every 10-K signal for Incyte and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Incyte this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/3e074422-e5f5-4747-87ba-53e1a5def043 returns this record as JSON. POST /v1/companies/enrich returns every signal for incyte.com.
{
"signal_id": "3e074422-e5f5-4747-87ba-53e1a5def043",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-02-17T06:34:03.067+00:00",
"company": {
"name": "Incyte",
"domain": "incyte.com"
},
"data": {
"detail": "After addressing an FDA complete response letter, the company is preparing for a potential launch of a new once-daily formulation of its blockbuster drug, JAKAFI. This will require new marketing, sales enablement, and commercial support to manage the product line extension.",
"metrics": {
"timeframe": "next_year"
},
"summary": "Anticipates regulatory decision and potential commercial launch of JAKAFI XR in mid-2026",
"excerpts": "A response to the CRL has been submitted and we anticipate a regulatory decision and potential commercial launch in mid-2026.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm",
"filing_date": "2026-02-10",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/3e074422-e5f5-4747-87ba-53e1a5def043 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"incyte.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.